Document is current
Any future updates will be listed below
-
Authors
Chang, So-Young
Kang, Jee Hyun
Ahn, Kwang Sung
Choi, Ji Eun
Park, Sang Min
Heo, Soon Young
Jung, Jae Yun
Lee, Min Young
Shim, Hosup
-
Funding
Funding for this research was provided by:
National Research Foundation of Korea (NRF) funded by the Ministry of Education (RS-2020-NR049585)
National Research Foundation (NRF) funded by the Korean government (RS-2023-00220408)
- License Information
-
More Information
Article History
Received: 15 March 2026
Accepted: 29 July 2026
First Online: 3 August 2026
Declarations
Ethics approval and consent to participate: Human dermal fibroblasts (HDFs) were purchased from Genlantis (now AMSBIO, San Diego, USA). According to the supplier, the cells were obtained from donors who received prior ethical approval and provided written informed consent. This study was exempt from Institutional Review Board (IRB) approval because the cells were commercially available and ethically sourced. Additional information about cell sources and ethical compliance can be found on the website ( ).The project title approved for animal study is “Development of auditory neural (spiral ganglion) regenerative therapy via delivery of target-specific nanohydrogel encapsulated neural stem cells and photoactivated differentiation.” Animal care and all experimental procedures were performed in accordance with the protocol approved by the Animal Care and Use Committee of Dankook University (approval number DKU-23–044, approval date: June 15, 2023).
Consent for publication: Not applicable.
Competing interest: he authors declare no competing interests.
